ArticleJournal of experimental & clinical cancer research : CR2019
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Jiao Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
60 papers cite it
this paperpooled itcites it